Total Microvessel Perimeter Per Tumor Area Is a Predictor of Radiosensitivity in Early-Stage Glottic Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1104-1109

  Zhang, Shichuan ^a   Hayashi, Ryuichi ^b   Fujii, Masato ^c   Hasegawa, Yasuhisa ^d   Yoshino, Kunitoshi ^e   Fukayama, Masashi ^f   Ochiai, Atsushi ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Glottic cancer; Microvessel perimeter; Radiosensitivity

Indexed keywords

BIOPSY; BLOOD VESSELS; DECISION MAKING; IMAGE ANALYSIS; MULTIVARIANT ANALYSIS; RADIOTHERAPY; TUMORS;

COMPUTER-ASSISTED; COMPUTER-ASSISTED ANALYSIS; CUT-OFF VALUES; GLOTTIC CANCER; GLOTTIC CARCINOMAS; IMAGE ANALYSIS SYSTEMS; MICRO VESSELS; MICROVESSEL PERIMETER; MULTI-VARIATE ANALYSIS; PREDICTIVE FACTORS; PROGRESSION-FREE SURVIVALS; RADICAL RADIOTHERAPIES; RADIOSENSITIVITY; RECEIVER OPERATING CHARACTERISTIC CURVE ANALYSIS; SURVIVAL ANALYSIS; TUMOR AREAS;

COMPUTER AIDED ANALYSIS;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; JAPAN; LARYNGEAL BIOPSY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PERIMETER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOSENSITIVITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIATION TOLERANCE; ROC CURVE; YOUNG ADULT;

EID: 61349201539     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.05.038     Document Type: Article

References (21)

1. Mendenhall W.M., Werning J.W., Hinerman R.W., et al. Management of T1-T2 glottic carcinomas. Cancer 100 (2004) 1786-1792
2. Mendenhall W.M., Amdur R.J., Morris C.G., et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19 (2001) 4029-4036
3. Le Q.T., Fu K.K., Kroll S., et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 115-126
4. Garden A.S., Forster K., Wong P.F., et al. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?. Int J Radiat Oncol Biol Phys 55 (2003) 322-328
5. Kamijo T., Yokose T., Hasebe T., et al. Image analysis of microvessel surface area predicts radiosensitivity in early-stage laryngeal carcinoma treated with radiotherapy. Clin Cancer Res 7 (2001) 2809-2814
6. Zhang S., Hironaka S., Ohtsu A., et al. Computer-assisted analysis of biopsy specimen microvessels predicts the outcome of esophageal cancers treated with chemoradiotherapy. Clin Cancer Res 12 (2006) 1735-1742
7. Golen M., Skladowski K., and Maciejewski B. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy. Neoplasma 46 (1999) 66-71
8. Pekkola-Heino K., Jaakkola M., Kulmala J., et al. Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma. J Cancer Res Clin Oncol 121 (1995) 452-456
9. Van den Bogaert W., van der Schueren E., Horiot J.C., et al. The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol 35 (1995) 91-99
10. Lo S.M., Venkatesan V., Matthews T.W., et al. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma. J Otolaryngol 27 (1998) 247-251
11. Walter M.A., Peters G.E., and Peiper S.C. Predicting radioresistance in early glottic squamous cell carcinoma by DNA content. Ann Otol Rhinol Laryngol 100 (1991) 523-526
12. Westerbeek H.A., Mooi W.J., Hilgers F.J., et al. Ploidy status and the response of T1 glottic carcinoma to radiotherapy. Clin Otolaryngol Allied Sci 18 (1993) 98-101
13. Toffoli G., Franchin G., Barzan L., et al. Brief report: prognostic importance of cellular DNA content in T1-2 N0 laryngeal squamous cell carcinomas treated with radiotherapy. Laryngoscope 105 (1995) 649-652
14. Miyaguchi M., Olofsson J., and Hellquist H.B. Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol Allied Sci 16 (1991) 466-469
15. Narayana A., Vaughan A.T., Kathuria S., et al. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 46 (2000) 21-26
16. Condon L.T., Ashman J.N., Ell S.R., et al. Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int J Cancer 100 (2002) 472-475
17. Kamijo T., Yokose T., Hasebe T., et al. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin Cancer Res 6 (2000) 3159-3165
18. Thomlinson R.H., and Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9 (1955) 539-549
19. Dvorak H.F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
20. Konerding M.A., Miodonski A.J., and Lametschwandtner A. Microvascular corrosion casting in the study of tumor vascularity: A review. Scanning Microsc 9 (1995) 1233-1243 discussion 1243-1234
21. Eberhard A., Kahlert S., Goede V., et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies. Cancer Res 60 (2000) 1388-1393